Valuation: ResMed Inc.

Market Cap 30.91B 26.96B 25.15B 23.12B 43.4B 2,956B 44.42B 298B 116B 1,465B 116B 114B 5,049B P/E 2026 *
20.2x
P/E 2027 * 18.9x
Enterprise Value 30.08B 26.24B 24.48B 22.51B 42.24B 2,877B 43.23B 290B 113B 1,425B 113B 110B 4,914B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 4.9x
Free-Float
75.61%
Yield 2026 *
1.13%
Yield 2027 * 1.22%
1 day+2.89%
3 months-32.82%
6 months-40.29%
Current year-37.45%
Current year 11.85
Extreme 11.85
37.91
1 year 11.85
Extreme 11.85
37.91
3 years 11.85
Extreme 11.85
37.91
5 years 1.9
Extreme 1.9
37.91
10 years 0
Extreme 0
37.91
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Change 5-day change 1-year change 3-year change Capi.($)
+2.89%-.--% - - 30.14B
+0.01%+10.12%+18.87%+2.60% 214B
-1.29%+9.76%-3.18%-24.45% 140B
-2.40%+0.87%-28.52%+8.14% 128B
-0.04%+6.60%-56.50%-10.93% 68.46B
+2.49%+1.43%+9.26%+2.41% 48.18B
+4.51%+8.78%-21.58%-28.66% 45.56B
-0.17%+5.60%+17.37%+11.31% 39.69B
-1.15%+3.25%+25.51%+32.79% 37.69B
+0.95%+1.19%+77.30%+1.24% 29.2B
Average +1.08%+4.06%+4.28%-0.62% 83.42B
Weighted average by Cap. +0.84%+5.13%-0.73%-2.72%

Financials

2026 *2027 *
Net sales 5.65B 4.93B 4.6B 4.23B 7.93B 540B 8.12B 54.49B 21.29B 268B 21.21B 20.75B 923B 5.97B 5.2B 4.86B 4.46B 8.38B 571B 8.58B 57.55B 22.49B 283B 22.4B 21.92B 975B
Net income 1.55B 1.35B 1.26B 1.16B 2.17B 148B 2.22B 14.91B 5.83B 73.27B 5.81B 5.68B 253B 1.61B 1.41B 1.31B 1.21B 2.26B 154B 2.32B 15.54B 6.07B 76.36B 6.05B 5.92B 263B
Net Debt -827M -721M -673M -618M -1.16B -79.06B -1.19B -7.97B -3.11B -39.17B -3.1B -3.04B -135B -1.65B -1.44B -1.34B -1.23B -2.31B -157B -2.37B -15.88B -6.2B -78.02B -6.18B -6.05B -269B
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
28/07/26 $0.000000 - 4
27/07/26 $0.000000 - 2
23/07/26 $0.000000 - 1
22/07/26 $0.000000 - 3
21/07/26 $0.000000 - 2
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
214.29USD
Average target price
248.60USD
Spread / Average Target
+16.01%

Quarterly revenue - Rate of surprise